Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Gago

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Breast Cancer Research and Treatment|June 28, 2005
Predictive value of apoptosis, proliferation, HER-2, and topoisomerase IIalpha for anthracycline chemotherapy in locally advanced breast cancerG Arpino, D R Ciocca, H Weiss, et al.
Journal of Medicinal Chemistry|June 1, 2001
Identification of a putative binding site for [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine (TSAO) derivatives at the p51-p66 interface of HIV-1 reverse transcriptaseF Rodríguez-Barrios, C Pérez, E Lobatón, et al.
Antimicrobial Agents and Chemotherapy|October 10, 2012
Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clonesGabriel Cabot, Alain A Ocampo-Sosa, M Angeles Domínguez, et al.
Journal of Medicinal Chemistry|November 7, 1998
Abasic analogues of TSAO-T as the first sugar derivatives that specifically inhibit HIV-1 reverse transcriptaseS Velázquez, C Chamorro, M J Pérez-Pérez, et al.
The ISME Journal|October 23, 2024
Ecological success of extreme halophiles subjected to recurrent osmotic disturbances is primarily driven by congeneric species replacementEsteban Bustos-Caparros, Tomeu Viver, Juan F Gago, et al.
Molecular Genetics and Metabolism Reports|February 27, 2020
Natural history of the late-onset phenotype of Fabry disease due to the p.F113L mutationOlga Azevedo, Miguel F Gago, Gabriel Miltenberger-Miltenyi, et al.
Molecular Genetics and Metabolism|September 15, 2019
Founder effect of Fabry disease due to p.F113L mutation: Clinical profile of a late-onset phenotypeOlga Azevedo, Andreas Gal, Rui Faria, et al.
British Journal of Pharmacology|October 28, 2010
PM01183, a new DNA minor groove covalent binder with potent in vitro and in vivo anti-tumour activityJ F M Leal, M Martínez-Díez, V García-Hernández, et al.
The ISME Journal|August 4, 2025
Global dominance of Haloquadratum walsbyi by a single genomovar with distinct gene content and viral cohorts from close relativesEsteban Bustos-Caparros, Tomeu Viver, Juan F Gago, et al.
Systematic and Applied Microbiology|March 25, 2023
Description of two cultivated and two uncultivated new Salinibacter species, one named following the rules of the bacteriological code: Salinibacter grassmerensis sp. nov.; and three named following the rules of the SeqCode: Salinibacter pepae sp. nov., Salinibacter abyssi sp. nov., and Salinibacter pampae sp. novTomeu Viver, Roth E Conrad, Marianna Lucio, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Breast Cancer Research and Treatment|June 28, 2005
Predictive value of apoptosis, proliferation, HER-2, and topoisomerase IIalpha for anthracycline chemotherapy in locally advanced breast cancerG Arpino, D R Ciocca, H Weiss, et al.
Journal of Medicinal Chemistry|June 1, 2001
Identification of a putative binding site for [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine (TSAO) derivatives at the p51-p66 interface of HIV-1 reverse transcriptaseF Rodríguez-Barrios, C Pérez, E Lobatón, et al.
Antimicrobial Agents and Chemotherapy|October 10, 2012
Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clonesGabriel Cabot, Alain A Ocampo-Sosa, M Angeles Domínguez, et al.
Journal of Medicinal Chemistry|November 7, 1998
Abasic analogues of TSAO-T as the first sugar derivatives that specifically inhibit HIV-1 reverse transcriptaseS Velázquez, C Chamorro, M J Pérez-Pérez, et al.
The ISME Journal|October 23, 2024
Ecological success of extreme halophiles subjected to recurrent osmotic disturbances is primarily driven by congeneric species replacementEsteban Bustos-Caparros, Tomeu Viver, Juan F Gago, et al.
Molecular Genetics and Metabolism Reports|February 27, 2020
Natural history of the late-onset phenotype of Fabry disease due to the p.F113L mutationOlga Azevedo, Miguel F Gago, Gabriel Miltenberger-Miltenyi, et al.
Molecular Genetics and Metabolism|September 15, 2019
Founder effect of Fabry disease due to p.F113L mutation: Clinical profile of a late-onset phenotypeOlga Azevedo, Andreas Gal, Rui Faria, et al.
British Journal of Pharmacology|October 28, 2010
PM01183, a new DNA minor groove covalent binder with potent in vitro and in vivo anti-tumour activityJ F M Leal, M Martínez-Díez, V García-Hernández, et al.
The ISME Journal|August 4, 2025
Global dominance of Haloquadratum walsbyi by a single genomovar with distinct gene content and viral cohorts from close relativesEsteban Bustos-Caparros, Tomeu Viver, Juan F Gago, et al.
Systematic and Applied Microbiology|March 25, 2023
Description of two cultivated and two uncultivated new Salinibacter species, one named following the rules of the bacteriological code: Salinibacter grassmerensis sp. nov.; and three named following the rules of the SeqCode: Salinibacter pepae sp. nov., Salinibacter abyssi sp. nov., and Salinibacter pampae sp. novTomeu Viver, Roth E Conrad, Marianna Lucio, et al.
Pageof 8